Advertisement

Topics

FDA Accepts Medivir's IND Application for MIV-711

14:00 EDT 17 Aug 2017 | Drug Discovery Development

MIV-711 is being developed to slow or reverse the progressive degeneration of joints affected by osteoarthritis.
Contributed Author: 
Medivir
Topics: 

Original Article: FDA Accepts Medivir's IND Application for MIV-711

NEXT ARTICLE

More From BioPortfolio on "FDA Accepts Medivir's IND Application for MIV-711"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Arthritis
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...